We are a development-stage manufacturer of minimally invasive endovascular medical devices for the treatment of vascular thrombosis. ALFAJET, our versatile proprietary platform technology, is a thrombectomy device designed for safe and effective thrombus removal from veins, arteries and arteriovenous dialysis conduits. 
Thrombosis is a steadily growing burden for health care systems globally, involving more than 70 million patients annually and growing every year. 
Our disruptive and scalable platform technology has the potential to offer distinct advantages over current thrombus removal methods. It does not require dedicated capital equipment or specialized on-site support, allowing easy utilization at any clinic worldwide. Its innovative design allows removal of large, semi organized clots without significant complications. Its low production and support cost allows fast market penetration. 
Our first product is designed to remove thrombus from peripheral veins, a $1.8 billion annual market. Our unique technology can be scaled for different-size vessels. The peripheral venous product can be followed by products designed to remove thrombus from Peripheral Arteries, Arteriovenous dialysis conduits, Coronary arteries etc.

FLOW MEDICAL CORP

Org chart

Teams

Offices

FLOW MEDICAL CORP

Org chart

Teams

Offices

Related companies